Epitome Residency Private Limited

Epitome Residency Private Limited - real estate and construction in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U45100MH2008PTC184241 Incorporated 03 July 2008 ROC Mumbai HQ Mumbai, Maharashtra, India
Under Insolvency Private Limited Company real estate and construction
Data last updated
Revenue · FY 2020
₹78.17 Cr
▲ 77% YoY
Net loss · FY 2020
₹46.63 Cr
Net margin -59.7%
EBITDA · FY 2020
₹20.35 Cr
EBITDA margin 26%
Authorised capital
₹3.75 Cr
Registered with MCA
Paid-up capital
₹1.4 Lakh
Issued & subscribed
Open charges
₹147 Cr
Satisfied ₹700.36 Cr
Company age
18 yrs
Est. 2008
Employees · EPFO
34
Provident fund records

About Epitome Residency Private Limited

Data last updated:

Epitome Residency Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Wadhwagroup Holdings Private Limited. The company is currently undergoing Corporate Insolvency Resolution Process (CIRP) under the Insolvency and Bankruptcy Code, 2016. Management control has been transferred to an insolvency professional. It operates in the real estate development and construction segment of the real estate and construction sector. It was incorporated on 03 July 2008.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U45100MH2008PTC184241. Its GSTIN is 27AAACW8040P1ZT (Maharashtra).

The company has an authorised share capital of ₹3.75 Cr and a paid-up capital of ₹1.4 Lakh. It was formerly known as Epitome Realty Projects Private Limited and Wadhwa Power Private Limited. It is led by directors including Sanjay Rajkumar Chhabria and Anil Nandlal Chhabria.

Its last annual general meeting (AGM) was held on 30 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at Mumbai, Maharashtra.

As per the financials filed for FY 2020, the company reported a revenue of ₹78.17 Cr, a growth of 77% compared to the previous year. For the same year it recorded a net loss of ₹46.63 Cr (net margin -59.7%) and EBITDA of ₹20.35 Cr (EBITDA margin 26%). Revenue has declined at a compounded annual rate (CAGR) of 34% over three years.

The company has about 34 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹147 Cr and satisfied charges of ₹700.36 Cr on record. Court records list 120 cases involving the company, including 3 filed by the company and 117 filed against it; 74 cases are pending. The company has 6 deals on record (5 secondary share transfers, 1 funding round), with disclosed funding of ₹3.53 Cr; the latest was in March 2017.

The last known website on record is radiusdevelopers.com.

Company details

CIN U45100MH2008PTC184241
Registration Number 184241
Incorporation Date 03 July 2008
ROC Mumbai
Listing Status Unlisted
Company Status Under CIRP
Date of Last AGM 30 December 2020
Date of Balance Sheet 31 March 2020
Parent Company Wadhwagroup Holdings Private Limited
Compliance Status Active Compliant

Name history

Epitome Residency has undergone 5 name changes throughout its history. The current legal name is Epitome Residency Private Limited.

Company NameStatus
Epitome Residency Private LimitedCurrent
Epitome Realty Projects Private LimitedPrevious
Wadhwa Power Private LimitedPrevious
Epitome Real Estates Private LimitedPrevious
Epitome Realty Private LimitedPrevious
Eptiome Estate Projects Private LimitedPrevious

CIN history

Epitome Residency has one previous CIN (Corporate Identification Number): U40102MH2008PTC184241. The current CIN is U45100MH2008PTC184241, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U45100MH2008PTC184241Current
U40102MH2008PTC184241Previous

Contact details

Epitome Residency Private Limited's registered office is in Mumbai, Maharashtra. Its website is radiusdevelopers.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    One BKC A Wing 1401 Plot No. C – 66 G Block Bandra Kurla Complex Bandra (E, Ast), Mumbai, Maharashtra, India – 400051
  • Industry
    Real Estate and Construction, Real Estate Builders & Developers

To see the full contact details of Epitome Residency Private Limited, buy the company report.

Comprehensive company report
Epitome Residency Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Epitome Residency is construction. In detail, this covers buildings.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
FConstructionF1Buildings

To see the full business activity and turnover split of Epitome Residency Private Limited, buy the company report.

Financials of Epitome Residency Private Limited

FY 2020 filings available

Epitome Residency Private Limited reported revenue of ₹78.17 Cr (up 77% YoY) for FY 2020.

Revenue · FY 2020
₹78.17 Cr ▲ 77%
Net loss · FY 2020
₹46.63 Cr margin -59.7%
EBITDA · FY 2020
₹20.35 Cr margin 26%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 77%
3 years · compounded
▼ 34%
EBITDA CAGR growth
1 year
▲ 163%
3 years · compounded
▼ 37%
5 years · compounded
▲ 399%

Revenue rose 77% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 34%. EBITDA rose 163% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2019-20FY 2018-19FY 2017-18FY 2016-17FY 2015-16
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹20.35 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹46.63 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2019-20FY 2018-19FY 2017-18FY 2016-17FY 2015-16
Profitability
EBITDA Margin26%
Net Profit Margin-59.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Epitome Residency Private Limited, buy the company report.

Board of directors of Epitome Residency Private Limited

Epitome Residency has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Sanjay Rajkumar ChhabriaDirector31 Mar 20179 Years 6 MonthsAs last reported
Anil Nandlal ChhabriaDirector31 Mar 20179 Years 6 MonthsAs last reported
Bharat Ramakant UpadhyayIrp/Rp/Liquidator29 May 20251 Years 4 MonthsAs last reported

Auditor

Epitome Residency Private Limited is audited by K KANKANI & CO for the financial year 2019.

Auditor firmFinancial yearFirm registration number
K KANKANI & COFY 2019139958W

Shareholding

The shareholding of Epitome Residency Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2019FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Epitome Residency Private Limited, buy the company report.

Charges & borrowings

Open charges
₹147 Cr
Satisfied charges
₹700.36 Cr
Breakdown by lending institutions
Others₹147.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
11 Sep 2017100151138Others₹45 CrOpen
13 Apr 2017100101154Others₹45 CrOpen
13 Apr 2017100101155Others₹57 CrOpen
16 Sep 2019100291615Others₹288.86 CrSatisfied
16 Sep 2019100291611Others₹267 CrSatisfied

To see the full charge records of Epitome Residency Private Limited, buy the company report.

Total charge records: 9 View all charges

Deals & funding

Epitome Residency Private Limited has 6 deals on record (5 secondary share transfers, 1 funding round), with disclosed funding of ₹3.53 Cr; the latest was in March 2017.

Total deals
6
Secondary share transfers
5
Funding round
1
Disclosed funding
₹3.53 Cr

Deals on record (5 of 6)

WhenDealAmountParties
Mar 2017Secondary share transferUndisclosedBuyer: 2 individuals
Seller: Wadhwagroup Holdings Private Limited , Wadhwagroup Holdings Private Limited & Vijay Vasudev Wadhwa
May 2010Secondary share transferUndisclosedBuyer: Wadhwagroup Holdings Private Limited , Wadhwagroup Holdings Private Limited & Vijay Vasudev Wadhwa
Seller: 4 individuals
Mar 2010Secondary share transferUndisclosedBuyer: an individual
Seller: 2 individuals
Feb 2010Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Jan 2010Secondary share transferUndisclosedBuyer: 2 individuals
Seller: 2 individuals

To see the full deal history of Epitome Residency Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Epitome Residency Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Epitome Residency Private Limited has a workforce of 34 employees on its EPFO records as of Apr 02, 2024, across 2 active EPFO establishments.

Employee count
34
Active EPFO establishments
2
Employee growth
-46.03%

GST

Epitome Residency has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAACW8040P1ZTMaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Epitome Residency Private Limited, buy the company report.

Recent activity

Epitome Residency Private Limited has 9 board changes on record since 2014: 3 appointments and 6 cessations. The latest: Bharat Ramakant Upadhyay was appointed as Irp/Rp/Liquidator on 29 May 2025.

Appointed
Bharat Ramakant Upadhyay was appointed as Irp/Rp/Liquidator.
Ceased
Ashok Venkatrao Barbole ceased to be Irp/Rp/Liquidator.
Charges
A charge registered on 16 Sep 2019 via Charge ID 100291615 with Others was fully satisfied on 25 Apr 2021.
Charges
A charge registered on 16 Sep 2019 via Charge ID 100291611 with Others was fully satisfied on 25 Apr 2021.
AGM
Epitome Residency Private Limited last Annual general meeting of members was held on 30 Dec 2020 as per latest MCA records.
Filing
Epitome Residency Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Mumbai.
Ceased
Jiten Bhagwan Uttwani ceased to be Additional Director.
Charges
A charge with Others amounted to Rs. 288.86 Cr with Charge ID 100291615 was registered on 16 Sep 2019.
Charges
A charge with Others amounted to Rs. 267.00 Cr with Charge ID 100291611 was registered on 16 Sep 2019.
Charges
A charge registered on 13 Apr 2017 via Charge ID 100101151 with Others was fully satisfied on 25 Sep 2018.
Charges
A charge registered on 13 Apr 2017 via Charge ID 100101157 with Others was fully satisfied on 25 Sep 2018.
Charges
A charge registered on 08 Jun 2017 via Charge ID 100139635 with Others was fully satisfied on 24 Sep 2018.

15 earlier events are in the company report.

Frequently asked questions

Epitome Residency is undergoing "Corporate Insolvency Resolution Process" (CIRP) under the Insolvency and Bankruptcy Code, 2016. Management control has been transferred to an insolvency resolution professional. The company may not be able to independently enter into new commitments during this period. This is a high-risk status - verify the resolution status before any engagement.

Epitome Residency is a company under insolvency, formerly operating as a private limited company based in Mumbai, Maharashtra, India. The company works in real estate builders and developers, within the real estate and construction industry. It was incorporated on 03 July 2008 and is registered under CIN U45100MH2008PTC184241. Caution is advised - the company may not have the legal capacity to fulfil new agreements.

Epitome Residency has 3 current directors:

The latest financial statements of Epitome Residency on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 30 December 2020. Year-wise statements from 2015 are in the company report.

The CIN (Corporate Identification Number) of Epitome Residency is U45100MH2008PTC184241. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Epitome Residency has open charges of ₹147 Cr and satisfied charges of ₹700.36 Cr as per latest MCA filings.

Epitome Residency has 120 court cases on record: 3 filed by the company and 117 filed against it. 74 are pending. Most are in the district courts.

Epitome Residency was incorporated on 03 July 2008. It is registered with the Registrar of Companies, Mumbai.

Epitome Residency has 6 deals on record (5 secondary share transfers, 1 funding round), with disclosed funding of ₹3.53 Cr; the latest was in March 2017.

Bharat Ramakant Upadhyay was appointed as Irp/Rp/Liquidator on 29 May 2025. Ashok Venkatrao Barbole ceased to be Irp/Rp/Liquidator on 11 May 2024. Jiten Bhagwan Uttwani ceased to be Additional Director on 14 Oct 2019. Epitome Residency has 9 board changes on record in total.